Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Meridian Bioscience VIVO is 30.48%. Meridian Bioscience's revenue for the same period is $184.04 million. The trailing-twelve-month operating margin at Trinity Biotech plc TRIB is 19.75%. Trinity Biotech's PEG ratio is 1.38. The trailing-twelve-month operating margin at Neogen NEOG is 19.61%. Neogen's ROE for the same period is 11.33%. The trailing-twelve-month operating margin at Abaxis ABAX is 13.21%. Abaxis had $85.54 million in total cash for the latest quarter.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Trading IdeasDiagnostic Substances IndustryHighest Operating MarginSmall capssmall-cap stocks
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!